Loading…
Tango Therapeutics, Inc. is projected to rise to $27.00 by 2027, a +37% move from its current price of $19.65. TNGX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $18.76 | $19.67 | $20.62 | +0.10% |
| May 30 | $18.41 | $19.69 | $21.05 | +0.20% |
| May 31 | $18.16 | $19.71 | $21.39 | +0.29% |
| Jun 1 | $17.95 | $19.73 | $21.68 | +0.39% |
| Jun 2 | $17.77 | $19.75 | $21.95 | +0.49% |
| Jun 3 | $17.60 | $19.77 | $22.19 | +0.59% |
| Jun 4 | $17.46 | $19.79 | $22.42 | +0.69% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $17.46 | $19.79 | $22.42 | +0.69% |
| Week 2 | $16.69 | $19.92 | $23.78 | +1.38% |
| Week 3 | $16.15 | $20.06 | $24.91 | +2.08% |
| Week 4 | $15.73 | $20.20 | $25.94 | +2.78% |
| Week 5 | $15.37 | $20.34 | $26.90 | +3.49% |
| Week 6 | $15.07 | $20.48 | $27.82 | +4.20% |
| Week 7 | $14.81 | $20.62 | $28.71 | +4.92% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Tango Therapeutics, Inc. is a healthcare company focused on precision oncology. It concentrates on the discovery and development of drugs for defined patient populations with unmet medical need.
The company develops methylthioadenosine-cooperative PRMT5 inhibitors, including TNG462, which is in Phase 1/2 clinical trial for treating pancreatic and lung cancer; and TNG456, a brain-penetrant PRMT5 inhibitor for the treatment of glioblastoma. It is also developing TNG260, a co-repressor of repressor element-1 silencing transcription inhibitor to reverse the immune evasion effect of serine-threonine kinase (STK) 11 loss-of-function mutations to treat lung cancer. The company was founded in 2017 and is headquartered in Boston, Massachusetts.
Tango Therapeutics, Inc. trades under the symbol TNGX. It has a current price of $20.24 and a market capitalization of $2.93B, with a rank of 1746. The near-term and longer-term price outlook is captured in a multi-year forecast showing growth potential alongside a flat entry in 2026 before bullish momentum in subsequent years.
A major floor 43.3% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 41.3% above — a clean break opens room to run.
A major ceiling 55.1% above — clearing it would confirm fresh momentum.
Key TNGX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TNGX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $20.53 | Sell | $20.37 | Sell |
| MA 10 | $21.45 | Sell | $21.11 | Sell |
| MA 20 | $22.16 | Sell | $21.89 | Sell |
| MA 50 | $22.17 | Sell | $21.10 | Sell |
| MA 100 | $17.43 | Buy | $18.26 | Buy |
| MA 200 | $12.75 | Buy | $14.38 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 39.83 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -111.76 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.49 | Sell |
| ROC (12) | -14.64 | Sell |
| Bollinger %B (20,2) | 0.13 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.11 | Sell |
| Awesome (5,34) | -2.73 | Sell |
| Ultimate (7,14,28) | 36.68 | Neutral |
| Momentum (10) | -3.85 | Sell |
| Aroon Osc (25) | -100.00 | Sell |
| Hull MA (9) | 19.93 | Sell |
| ADX (14) | 18.79 | Neutral |
| ATR (14) | 0.88 | Info |
The 30-day technical picture shows bullish sentiment overall. The RSI(14) is 40, with the 50-day simple moving average at $22.08 and the 200-day simple moving average at $12.62. The current price sits at support of $20.24 and faces resistance at $27.77.
The 30-day range spans from $14.55 to $28.15, indicating substantial near-term price movement potential. Annualized volatility is 100%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $8.91 | $19.65 | $32.65 | 0% | Neutral | |
| $19.89 | $27.00 | $39.54 | +37% | Bullish | |
| $26.64 | $38.05 | $58.91 | +94% | Bullish | |
| $36.24 | $54.08 | $87.45 | +175% | Bullish | |
| $41.09 | $63.81 | $106.99 | +225% | Bullish | |
| $43.84 | $70.64 | $122.21 | +260% | Bullish | |
| $42.88 | $71.56 | $127.31 | +264% | Bullish | |
| $47.93 | $82.72 | $150.90 | +321% | Bullish | |
| $51.65 | $92.09 | $171.90 | +369% | Bullish | |
| $55.30 | $101.76 | $194.02 | +418% | Bullish | |
| $79.02 | $169.15 | $351.97 | +761% | Bullish | |
| $228.10 | $506.88 | $1,165.83 | +24.8x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $8.91 | $19.65 | $23.43 | +0.00% |
| June 2026 | $17.77 | $21.20 | $26.15 | +7.91% |
| July 2026 | $17.74 | $21.49 | $27.10 | +1.33% |
| August 2026 | $17.61 | $21.58 | $27.69 | +0.42% |
| September 2026 | $18.91 | $23.40 | $30.46 | +8.46% |
| October 2026 | $19.94 | $24.89 | $32.80 | +6.36% |
| November 2026 | $19.33 | $24.33 | $32.41 | -2.27% |
| December 2026 | $19.13 | $24.25 | $32.65 | -0.30% |
Click any year to see its month-by-month TNGX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, TNGX is projected to trade between $8.91 and $32.65, averaging $19.65 — a potential gain of 0% from today's $19.65. Price action looks broadly range-bound.
Tango Therapeutics, Inc.'s 2027 outlook centres on $27.00, within a $19.89 to $39.54 range. That is up +37% on the projected 2026 average. That marks a +37% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, TNGX could reach as high as $58.91, with a base case around $38.05 and support toward $26.64 — roughly +94% from $19.65. Momentum favours further upside here.
Expect TNGX to range from $36.24 to $87.45 through 2029. The $54.08 average target implies a +175% move from current prices. That is up +42% on the projected 2028 average. Buyers look set to stay in control over this stretch.
The TNGX price prediction for 2030 points to an average of $63.81 (low $41.09, high $106.99) — a potential gain of +225% on today's $19.65. Momentum favours further upside here.
In 2031, TNGX is projected to trade between $43.84 and $122.21, averaging $70.64 — a potential gain of +260% from today's $19.65. That is up +11% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Tango Therapeutics, Inc.'s 2032 outlook centres on $71.56, within a $42.88 to $127.31 range. That is up +1% on the projected 2031 average. That marks a +264% change versus current levels. Momentum favours further upside here.
By 2033, TNGX could reach as high as $150.90, with a base case around $82.72 and support toward $47.93 — roughly +321% from $19.65. Buyers look set to stay in control over this stretch.
Expect TNGX to range from $51.65 to $171.90 through 2034. The $92.09 average target implies a +369% move from current prices. That is up +11% on the projected 2033 average. Momentum favours further upside here.
The TNGX price prediction for 2035 points to an average of $101.76 (low $55.30, high $194.02) — a potential gain of +418% on today's $19.65. Buyers look set to stay in control over this stretch.
In 2040, TNGX is projected to trade between $79.02 and $351.97, averaging $169.15 — a potential gain of +761% from today's $19.65. That is up +66% on the projected 2035 average. Momentum favours further upside here.
Tango Therapeutics, Inc.'s 2050 outlook centres on $506.88, within a $228.10 to $1,165.83 range. That is up +200% on the projected 2040 average. That marks a +24.8x change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in TNGX today (≈ 50.890585 TNGX) could be worth
$25,795.48
+$24,795.48 (+2480%) by 2050 · US Dollar
Based on the average projected TNGX price of $506.88 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TNGXwould be worth at today's price.
$1,000 invested in TNGX on May 27, 2025 (≈ 487.804889 TNGX) would be worth
$9,585.37
+$8,585.37 (+858.5%) today · 9.59× · US Dollar
Based on a TNGX entry price of $2.05 vs. today's $19.65.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $21.08 | $932.16 | -6.8% |
| 1 month ago | $26.33 | $746.3 | -25.4% |
| 3 months ago | $11.4 | $1,723.68 | +72.4% |
| 6 months ago | $10.91 | $1,801.1 | +80.1% |
| 1 year ago | $2.05 | $9,585.37 | +858.5% |
| All time (5.0y) ago | $11.03 | $1,781.51 | +78.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TNGX forecast.
Our base-case forecast reaches $39.00 around 2029.
Implied market cap at $39.00: $5.64B
The multi-year forecast outlines a trajectory from a neutral near-term in 2026 to a sustained bullish outlook in the following years. In 2026, the average price is $20.24 with a min of $8.91 and a max of $34.41, and a 0% ROI. From 2027 onward, the model envisions a rising path: 2027 average $28.17, 2028 $40.25, 2029 $57.77, 2030 $66.29, 2031 $72.03, 2032 $73.95, 2033 $84.37, 2034 $93.70, and 2035 $107.54, all with bullish sentiment and improving ROI (e.g., 227.5% in 2030, 255.9% in 2031, 265.4% in 2032, 316.8% in 2033, 362.9% in 2034, 431.3% in 2035).
The longer-horizon forecast shows significant upside: 2040 reflects an average of $169.43 with a min of $76.24, max of $361.69 and a ROI of 737.1% (bullish). By 2050, the average is projected at $527.00, with a min of $237.15, max of $1,212.10 and a ROI of 2503.8% (bullish). These figures imply meaningful upside potential over the next two decades, though they are estimates and not guarantees.
Tap a question to reveal the answer.
In 2030, the forecast shows an average price of $66.29, with a range from $41.79 to $113.19, and a 227.5% ROI; sentiment is BULLISH.
In 2040, the forecast shows an average price of $169.43, with a range from $76.24 to $361.69, and a 737.1% ROI; sentiment is BULLISH.
In 2050, the forecast shows an average price of $527.00, with a range from $237.15 to $1,212.10, and a 2503.8% ROI; sentiment is BULLISH.
The forecast shows bullish sentiment from 2027 onward with rising averages and notable ROI: 39.2% in 2027, 98.9% in 2028, 185.4% in 2029, 227.5% in 2030, 255.9% in 2031, 265.4% in 2032, 316.8% in 2033, 362.9% in 2034, and 431.3% in 2035, culminating in 737.1% in 2040 and 2503.8% in 2050. These are estimates and not guarantees.
Yes. The 2050 forecast lists a max of $1,212.10, indicating a potential exceedance of $1,000 in the long term.
Tango Therapeutics, Inc. Community Discussion
0Share your Tango Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.